Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What level of serum calcitonin indicates medullary thyroid carcinoma in patients with chronic kidney disease?

Nature Clinical Practice Nephrology volume 3, pages 246–247 (2007)Cite this article

boxed-textBorchhardt K A et al. (2006) Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia. Kidney Int 70: 2014–2020

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Leboulleux S et al. (2004) Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61: 299–310

    Article  Google Scholar 

  2. Messa P et al. (1995) The calcitonin–calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function. Nephrol Dial Transplant 10: 2259–2265

    Article  CAS  Google Scholar 

  3. Karanikas G et al. (2004) Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 89: 515–519

    Article  CAS  Google Scholar 

  4. Costante G et al. (2007) Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92: 450–455

    Article  CAS  Google Scholar 

  5. Papi G et al. (2006) Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: a multicenter study. J Endocrinol Invest 29: 427–437

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Hospital Georges Pompidou, Department of Nephrology, University Paris V, 20 rue Leblanc, Paris 75015, France alain.meyrier@brs.aphp.fr

Authors and Affiliations

  1. A Meyrier is a Senior Nephrologist in the Department of Nephrology at the Hospital Georges Pompidou, University of Paris René Descartes Medical School, Paris, France.,

    Alain Meyrier

Authors
  1. Alain Meyrier
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyrier, A. What level of serum calcitonin indicates medullary thyroid carcinoma in patients with chronic kidney disease?. Nat Rev Nephrol 3, 246–247 (2007). https://doi.org/10.1038/ncpneph0464

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0464

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing